Fennec Pharmaceuticals (TSE:FRX) Stock Crosses Above 50 Day Moving Average – Should You Sell?

Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$9.29 and traded as high as C$9.57. Fennec Pharmaceuticals shares last traded at C$9.57, with a volume of 5,399 shares trading hands.

Fennec Pharmaceuticals Price Performance

The stock has a market cap of C$184.55 million, a price-to-earnings ratio of -162.11 and a beta of 0.25. The company has a debt-to-equity ratio of -620.83, a quick ratio of 10.17 and a current ratio of 7.80. The company has a 50-day simple moving average of C$9.29 and a two-hundred day simple moving average of C$8.00.

Insider Activity at Fennec Pharmaceuticals

In related news, Director Rostislav Christov Raykov sold 7,569 shares of the stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of C$9.71, for a total value of C$73,503.54. Over the last three months, insiders sold 21,186 shares of company stock valued at $196,017. 16.20% of the stock is owned by corporate insiders.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.